Logo Medical Science Monitor

Call: +1.631.470.9640
Closed: National Holiday

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 May 2010

1H-MRS in mild cognitive impairment (MCI) – the role of particular metabolites in prediction of MCI conversion to AD

Jerzy Walecki, Agnieszka Pawłowska, Tomasz Gabryelewicz, Jarosław B. Ćwikła, Maria Barcikowska, Tomasz Nesteruk

Med Sci Monit 2010; 16(1): 11-18 :: ID: 880576

Abstract

Background: This study evaluated predictive value of brain 1H MRS in patients with MCI, who could have converted to Alzheimer disease (AS).
Material/Methods: The examination was performed on a group of 31 MCI subjects. All underwent neurologic and psychiatric tests, routine laboratory investigations, and standard neuropsychological examinations. MCI diagnosis was established based on criteria of the Mayo Clinic Group. ¹H MRS was performed with a single-voxel method using PRESS sequence. The VOI was located in the frontal, medial, and external temporal lobe regions.
Results: Patients had annual clinical control at least twice; in the beginning, 9 subjects were diagnosed as an amnestic MCI, and the others (22) had multidomain MCI. Baseline metabolic ratios (1H MRS) between 3 groups of patients, indicated significant difference in left frontal lobe in mI/H20 ratio, between patients with SD (0.27) and DP (0.22) (P=.03). There was a significant difference NAA/Cr (1.77 vs 1.43; P=.02). Significant differences within left temporal external lobes were found between patients with SD and DP in NAA/H2O ratio (0.55 vs 51; P=.04). Additional differences within medial temporal lobe were found between patients with DP and AD in Glx/H2O ratio (0.44 vs 0.34) on the right side (P=.02).
Conclusions: 1H MRS seems to be a sensitive method providing biochemical information using in vivo approach in patients with initial MCI, who, in significant numbers, developed a disease and/or converted to AD. Our findings concerning 1H MRS patients with MCI require further prospective studies.

Keywords: MCI, mild cognitive impairment, AD, Alzheimer’s disease • ¹H MRS, proton magnetic resonance spectroscopy

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Clinical Research  

Percutaneous Coronary Intervention as a Non-Surgical Treatment for Ischemic Mitral Regurgitation in Patient...

Med Sci Monit In Press; DOI: 10.12659/MSM.943122  

Clinical Research  

Maxillary Canine Impaction: Assessing the Influence of Maxillary Anatomy Using Cone Beam Computed Tomography

Med Sci Monit In Press; DOI: 10.12659/MSM.944306  

Clinical Research  

Optimal Duration of Cold and Heat Compression for Forearm Muscle Biomechanics in Mixed Martial Arts Athlete...

Med Sci Monit In Press; DOI: 10.12659/MSM.944149  

Clinical Research  

A Retrospective Study of the Presentation, Diagnosis, Management, and Outcomes of 27 Patients with Osteogen...

Med Sci Monit In Press; DOI: 10.12659/MSM.944364  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750